Eur Rev Med Pharmacol Sci 2022; 26 (20): 7561-7565
DOI: 10.26355/eurrev_202210_30030

Long term results of the use of a fusion-promoting, new generation interspinous processes device (IPD), Bacfuse®: a monocentric prospective study

A. Spallone

Ncl-Institute of Neurological Sciences, Rome, Italy. aldospallone@hotmail.com


OBJECTIVE: Lumbar micro instability is a diffuse problem mostly in elderly population. Interspinous processes devices (IPDs) have been introduced in the clinical practice for relieving the dynamic compression on the nerve roots due to instability. First-generation IPDs did not achieve bone fusion so their good immediate postoperative results did not last in the long term. More recently, a new version of IPD, Bacfuse®, has been introduced with the aim of achieving postoperative fusion.

SUBJECTS AND METHODS: We started using this new device in 2015. We investigated prospectively the long-term results of a series of 41 patients with small-to-moderate lumbar instability. In 29 of them the IPD was placed as an adjunct to decompressive surgery whilst in 12 patients it was implemented as a stand-alone technique.

RESULTS: Immediate post-operative results showed significant clinical improvement in all cases. This improvement was still present in 32 of them at the last follow-up, 2.5 to 4 years following surgery. The dynamics of clinical symptoms did not change after two years of observation, a fact that indicates that no changes are to be expected afterward. Spinal fusion was obtained in more than 2/3 of the patients and not surprisingly was correlated with better clinical results. Excessive body weight appeared to be a negative factor for achieving both spinal fusion and good results.

CONCLUSIONS: Bacfuse® seems to be a very good surgical tool for patients bearing small to moderate lumbar instability whether or not submitted to direct decompressive surgery.

Free PDF Download

To cite this article

A. Spallone
Long term results of the use of a fusion-promoting, new generation interspinous processes device (IPD), Bacfuse®: a monocentric prospective study

Eur Rev Med Pharmacol Sci
Year: 2022
Vol. 26 - N. 20
Pages: 7561-7565
DOI: 10.26355/eurrev_202210_30030